Isaac E. Ciechanover

2019

In 2019, Isaac E. Ciechanover earned a total compensation of $8M as Former President & Chief Executive Officer at Atara Biotherapeutics, a 31% increase compared to previous year.

Compensation breakdown

Option Awards$879,473
Salary$383,958
Stock Awards$5,862,564
Other$888,776
Total$8,014,771

Ciechanover received $5.9M in stock awards, accounting for 73% of the total pay in 2019.

Ciechanover also received $879.5K in option awards, $384K in salary and $888.8K in other compensation.

Rankings

In 2019, Isaac E. Ciechanover's compensation ranked 1,087th out of 13,971 executives tracked by ExecPay. In other words, Ciechanover earned more than 92.2% of executives.

ClassificationRankingPercentile
All
1,087
out of 13,971
92nd
Division
Manufacturing
375
out of 5,692
93rd
Major group
Chemicals And Allied Products
113
out of 2,189
95th
Industry group
Drugs
89
out of 1,875
95th
Industry
Biological Products, Except Diagnostic Substances
19
out of 389
95th
Source: SEC filing on April 22, 2020.

Ciechanover's colleagues

We found five more compensation records of executives who worked with Isaac E. Ciechanover at Atara Biotherapeutics in 2019.

2019

Pascal Touchon

Atara Biotherapeutics

Chief Executive Officer

2019

Dietmar Berger

Atara Biotherapeutics

Former Global Head of Research & Development

2019

Joseph Newell

Atara Biotherapeutics

EVP, Chief Technical Operations Officer

2019

Utpal Koppikar

Atara Biotherapeutics

Chief Financial Officer

2019

Mina Kim

Atara Biotherapeutics

General Counsel

News

You may also like